Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2009. Start Trial.
Date Value
November 17, 2026 10.64M
November 16, 2026 1.796M
November 13, 2026 11.84M
November 12, 2026 23.09M
November 11, 2026 15.44M
November 10, 2026 3.146M
November 09, 2026 4.195M
November 06, 2026 1.946M
November 05, 2026 -1.202M
November 04, 2026 -9.748M
November 03, 2026 -11.70M
November 02, 2026 -13.05M
October 30, 2026 -6.000M
October 29, 2026 -11.10M
October 28, 2026 -3.301M
October 27, 2026 -2.102M
October 26, 2026 -11.10M
October 23, 2026 50.97M
October 22, 2026 50.82M
October 21, 2026 46.18M
October 20, 2026 43.03M
October 19, 2026 24.14M
October 16, 2026 31.33M
October 15, 2026 36.73M
October 14, 2026 35.98M
Date Value
October 13, 2026 31.18M
October 12, 2026 28.63M
October 09, 2026 29.08M
October 08, 2026 28.33M
October 07, 2026 26.98M
October 06, 2026 30.73M
October 05, 2026 29.98M
October 02, 2026 34.48M
October 01, 2026 36.28M
September 30, 2026 41.08M
September 29, 2026 115.14M
September 28, 2026 116.19M
September 25, 2026 114.54M
September 24, 2026 120.53M
September 23, 2026 119.49M
September 22, 2026 123.38M
September 21, 2026 114.24M
September 18, 2026 110.20M
September 17, 2026 108.25M
September 16, 2026 105.10M
September 15, 2026 100.01M
September 14, 2026 100.91M
September 11, 2026 96.26M
September 10, 2026 97.61M
September 09, 2026 94.76M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.774B
Corcept Therapeutics, Inc. 7.301B
Veru, Inc. 13.38M
Johnson & Johnson 698.29B
Eli Lilly & Co. 1.377T